About Imbed Biosciences
Imbed Biosciences is a company based in Madison (United States) founded in 2010. Imbed Biosciences has raised $22.7 million across 19 funding rounds from investors including NIH, HHS and Niterra Ventures. The company has 35 employees as of December 31, 2022. Imbed Biosciences offers products and services including Surgaflex, PelashieldAM, and Microlyte Matrix. Imbed Biosciences operates in a competitive market with competitors including Adocia, Cresilon, Kane Biotech, Cour Pharma and Alafair Biosciences, among others.
- Headquarter Madison, United States
- Employees 35 as on 31 Dec, 2022
-
Sectors
TechnologyHealthcare Aerospace, Defense & Maritime
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imbed Biosciences, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.7 M (USD)
in 19 rounds
-
Latest Funding Round
Not available
-
Investors
NIH
& 7 more
-
Employee Count
35
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imbed Biosciences
Imbed Biosciences offers a comprehensive portfolio of products and services, including Surgaflex, PelashieldAM, and Microlyte Matrix.
Antimicrobial matrix for surgical wounds management.
Hydrophilic matrix for complex burn wound challenges.
Synthetic skin substitute for chronic wound healing.
People of Imbed Biosciences
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Imbed Biosciences
Imbed Biosciences has successfully raised a total of $22.7M across 19 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Imbed Biosciences
Imbed Biosciences has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Niterra Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovative ideas are transformed into reality by Niterra Ventures.
|
Locked | Locked | Locked | |
|
WISC Partners is engaged in providing expansion and acceleration capital.
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked |
Investor details for Imbed Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Imbed Biosciences
Investment portfolio details for Imbed Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imbed Biosciences
Detailed financials for Imbed Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imbed Biosciences Comparisons
Peer comparison for Imbed Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imbed Biosciences
Imbed Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Cresilon, Kane Biotech, Cour Pharma and Alafair Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| Locked | Locked | Locked |
Biotech nanoparticles are developed for immune disease treatments.
|
|
| Locked | Locked | Locked |
Biomaterials and devices for internal wound healing are developed.
|
Detailed competitors of Imbed Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imbed Biosciences
Complete news archive for Imbed Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imbed Biosciences
Imbed Biosciences was founded in 2010.
Imbed Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Imbed Biosciences is a funded company, having raised a total of $22.7M across 19 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Imbed Biosciences is 35.
Imbed Biosciences was founded in 2010 and is based in Madison, United States. Focus is placed on the biotechnology sector, where nanotechnology is applied to wound care. Bioactive molecules are embedded into dressings and surgical implants via the Microlyte Matrix platform. Antibacterial, anti-biofilm, and analgesic wound dressings are produced for medical use. Operations center on advancing these technologies for clinical applications.
Imbed Biosciences's top competitors include Adocia, Cresilon and Kane Biotech.
Imbed Biosciences offers Surgaflex, PelashieldAM, and Microlyte Matrix.
Imbed Biosciences has 8 investors. Key investors include NIH, HHS, Niterra Ventures, Formidable Asset Management, and WISC Partners.